Table 2. Univariate and multivariate analysis of factors related to DFS in TNBC cancer patients.
DFS | ||||
---|---|---|---|---|
variable | Univariate analysis | Multivariate analysis | ||
HR (95 % CI) | p value | HR (95 % CI) | p value | |
age | 1.471(0.752-2.876) | 0.259 | ||
TNM stage | 2.111(1.250-3.566) | 0.005 | 2.263(1.085-4.723) | 0.03 |
tumor size | 1.712(1.031-2.842) | 0.038 | 1.387(0.784-2.452) | 0.261 |
node status | 2.262(1.175-4.356) | 0.015 | 1.154(0.489-2.727) | 0.744 |
Pathological stage | 1.338(0.688-2.601) | 0.391 | ||
Menopausal status | 1.740(0.881-3.435) | 0.111 | ||
BRCA1 | 0.321(0.113-0.908) | 0.032 | 0.318(0.110-0.918) | 0.034 |
Anthracyclines based chemo | 0.677(0.339-1.354) | 0.270 | ||
Taxane based chemo | 1.555(0.731-3.308) | 0.252 | ||
AR | 2.258(1.155-4.414) | 0.017 | 2.423(1.211-4.848) | 0.012 |
Bold values are statistically significant (P < 0.05)
CI confidence interval
AR androgen receptor
BRCA1 breast cancer-associated gene1